Sangamo Therapeutics Statistics

Total Valuation

LON:0R1D has a market cap or net worth of GBP 91.67 million. The enterprise value is 91.45 million.

Market Cap	91.67M
Enterprise Value	91.45M

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	237.60M
Shares Outstanding	n/a
Shares Change (YoY)	+19.33%
Shares Change (QoQ)	+4.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	231.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.86
PB Ratio	24.14
P/TBV Ratio	24.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.49
EV / Sales	1.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.63

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 5.07.

Current Ratio	0.76
Quick Ratio	0.60
Debt / Equity	5.07
Debt / EBITDA	n/a
Debt / FCF	-0.55
Interest Coverage	-24.91

Financial Efficiency

Return on equity (ROE) is -257.94% and return on invested capital (ROIC) is -86.10%.

Return on Equity (ROE)	-257.94%
Return on Assets (ROA)	-46.95%
Return on Invested Capital (ROIC)	-86.10%
Return on Capital Employed (ROCE)	-220.73%
Revenue Per Employee	269,653
Profits Per Employee	-336,026
Employee Count	183
Asset Turnover	0.59
Inventory Turnover	n/a

Taxes

Income Tax	-113,003
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.31% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+57.31%
50-Day Moving Average	0.56
200-Day Moving Average	1.15
Relative Strength Index (RSI)	53.54
Average Volume (20 Days)	125,798

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.84

Income Statement

In the last 12 months, LON:0R1D had revenue of GBP 49.35 million and -61.49 million in losses. Loss per share was -0.29.

Revenue	49.35M
Gross Profit	-29.32M
Operating Income	-62.54M
Pretax Income	-61.61M
Net Income	-61.49M
EBITDA	-58.88M
EBIT	-62.54M
Loss Per Share	-0.29

Full Income Statement

Balance Sheet

The company has 19.49 million in cash and 19.25 million in debt, giving a net cash position of 235,293.

Cash & Cash Equivalents	19.49M
Total Debt	19.25M
Net Cash	235,293
Net Cash Per Share	n/a
Equity (Book Value)	3.80M
Book Value Per Share	0.02
Working Capital	-9.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -34.54 million and capital expenditures -206,655, giving a free cash flow of -34.75 million.

Operating Cash Flow	-34.54M
Capital Expenditures	-206,655
Free Cash Flow	-34.75M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -59.41%, with operating and profit margins of -126.73% and -124.61%.

Gross Margin	-59.41%
Operating Margin	-126.73%
Pretax Margin	-124.84%
Profit Margin	-124.61%
EBITDA Margin	-119.32%
EBIT Margin	-126.73%
FCF Margin	n/a

Dividends & Yields

LON:0R1D does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.33%
Shareholder Yield	n/a
Earnings Yield	-67.08%
FCF Yield	-37.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0R1D has an Altman Z-Score of -25.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.85
Piotroski F-Score	3